Docket No. | Op. Below | Argument | Opinion | Vote | Author | Term |
---|---|---|---|---|---|---|
09-1156 | 9th Cir. | Jan 10, 2011 | Mar 22, 2011 | 9-0 | Sotomayor | OT 2010 |
Holding: The plaintiffs have stated a claim for securities fraud under § 10(b) of the Securities and Exchange Act and SEC Rule 10b-5 based on a pharmaceutical company's failure to disclose reports of adverse events associated with a product, even if the reports do not disclose a statistically significant number of adverse events.
Plain English Holding: A drug company’s failure to make public reports of adverse drug reactions can constitute securities fraud, even if the number of adverse reactions is not statistically significant.
Judgment: Affirmed., 9-0, in an opinion by Justice Sotomayor on March 22, 2011.
NEW: The Supreme Court will review the legality of Biden's student-debt relief plan. The justices will hear oral argument in February. In the meantime, the plan remains blocked as a result of lower-court rulings.
Bribery or lobbying?
Percoco v. United States in a TikTok minute.
JUST IN: For the second time in the past week, SCOTUS denies an emergency request to block the execution of Kevin Johnson. The execution is scheduled for tonight in Missouri. Sonia Sotomayor and Ketanji Brown Jackson dissent from the brief order allowing the execution to proceed.
Cecilia (Cissy) Suyat Marshall, the widow of Thurgood Marshall, died this morning at 94. Here is the court's announcement.
Cecilia (Cissy) Suyat Marshall, the widow of Thurgood Marshall, died this morning at 94. Here is the court's announcement.
BREAKING: The Supreme Court REJECTS Trump's bid to prevent the House Ways & Means Committee from obtaining his tax returns. No noted dissents.
The brief order may end years of litigation over the committee's efforts to review the tax records of Trump and his businesses.